• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

MEEI has new laser to treat diabetic retinopathy

Article

The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy.

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy. The pattern scan laser photocoagulator (Pascal, OptiMedica) places an array of lower energy pulses across the retina, allowing patients to receive treatment in a single session as opposed to multiple sessions.

Also, the treatment results in less inflammation and blurring of vision after treatment.

"{MEEI's] acquisition of the laser, in combination with current technologies available at the hospital, including the retinal angiograph [Spectralis, Heidelberg] and optical coherence tomography (OCT), and spectral domain OCT [Carl Zeiss Meditec], make MEEI state of the art for retina diagnosis and treatment," said Joan W. Miller, MD, MEEI chief of ophthalmology and chairwoman of ophthalmology at Harvard Medical School. "Having the best tools helps our doctors give the very best care for patients."

Related Videos
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.